Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Gruenberger

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Acta Oncologica (Stockholm, Sweden)|October 25, 2007
Assessment of the role of hepatitis C, Helicobacter pylori and autoimmunity in MALT lymphoma of the ocular adnexa in 45 Austrian patientsBirgit Gruenberger, Stefan Woehrer, Marlene Troch, et al.
Annals of Surgical Oncology|February 24, 2010
Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOXMarkus Klinger, Dietmar Tamandl, Sandra Eipeldauer, et al.
The Lancet. Oncology|November 13, 2010
Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 studyBirgit Gruenberger, Johannes Schueller, Ute Heubrandtner, et al.
Surgery|April 26, 2008
Adequate preoperative staging rarely leads to a change of intraoperative strategy in patients undergoing surgery for colorectal cancer liver metastasesDietmar Tamandl, Beata Herberger, Birgit Gruenberger, et al.
BMC Immunology|November 1, 2014
Monocytes with angiogenic potential are selectively induced by liver resection and accumulate near the site of liver regenerationDominic Schauer, Patrick Starlinger, Philipp Zajc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2007
Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinomaBeata Herberger, Harald Puhalla, Martina Lehnert, et al.
Plos One|January 23, 2015
Deficiency in thrombopoietin induction after liver surgery is associated with postoperative liver dysfunctionStefanie Haegele, Florian Offensperger, David Pereyra, et al.
Journal of Hepatology|December 5, 2012
Clinical evidence for thrombospondin-1 as a relevant suppressor of liver regenerationPatrick Starlinger, Dominic Schauer, Lejla Alidzanovic, et al.
Cancers|March 13, 2024
Perioperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer: Long-Term Follow-Up of the ASSO-LM1 TrialYawen Dong, Jonas Santol, Birgit Gruenberger, et al.
Hepatology (Baltimore, Md.)|November 27, 2013
Evidence for serotonin as a relevant inducer of liver regeneration after liver resection in humansPatrick Starlinger, Alice Assinger, Stefanie Haegele, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Acta Oncologica (Stockholm, Sweden)|October 25, 2007
Assessment of the role of hepatitis C, Helicobacter pylori and autoimmunity in MALT lymphoma of the ocular adnexa in 45 Austrian patientsBirgit Gruenberger, Stefan Woehrer, Marlene Troch, et al.
Annals of Surgical Oncology|February 24, 2010
Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOXMarkus Klinger, Dietmar Tamandl, Sandra Eipeldauer, et al.
The Lancet. Oncology|November 13, 2010
Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 studyBirgit Gruenberger, Johannes Schueller, Ute Heubrandtner, et al.
Surgery|April 26, 2008
Adequate preoperative staging rarely leads to a change of intraoperative strategy in patients undergoing surgery for colorectal cancer liver metastasesDietmar Tamandl, Beata Herberger, Birgit Gruenberger, et al.
BMC Immunology|November 1, 2014
Monocytes with angiogenic potential are selectively induced by liver resection and accumulate near the site of liver regenerationDominic Schauer, Patrick Starlinger, Philipp Zajc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2007
Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinomaBeata Herberger, Harald Puhalla, Martina Lehnert, et al.
Plos One|January 23, 2015
Deficiency in thrombopoietin induction after liver surgery is associated with postoperative liver dysfunctionStefanie Haegele, Florian Offensperger, David Pereyra, et al.
Journal of Hepatology|December 5, 2012
Clinical evidence for thrombospondin-1 as a relevant suppressor of liver regenerationPatrick Starlinger, Dominic Schauer, Lejla Alidzanovic, et al.
Cancers|March 13, 2024
Perioperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer: Long-Term Follow-Up of the ASSO-LM1 TrialYawen Dong, Jonas Santol, Birgit Gruenberger, et al.
Hepatology (Baltimore, Md.)|November 27, 2013
Evidence for serotonin as a relevant inducer of liver regeneration after liver resection in humansPatrick Starlinger, Alice Assinger, Stefanie Haegele, et al.
Pageof 4